Abstract Two distinct series of the 3-amino-1,5-benzoxathiepin scaffold, derived from L-cysteine, were synthesized and evaluated for their anti-proliferative activity in the breast cancer MDA-MB-231 and MCF-7 cells, and in the ovarian carcinoma SKOV-3 cell line. (3R)-Amino-3,4-dihydro-2H-1,5-benzoxathiepin [(R)-10] was diversified into two forms: (a) by incorporating different amino acids at its position 3, through an amide bond; and (b) by construction of the purine ring to give 6-chloro-9-[2-(3,4-dihydro-2H-1,5-benzoxathiepin-(3R)-yl)]-9H-purine [(R)-28]. Nevertheless, when the introduction of iodine was tried at position 2 of the purine ring of (R)-28, 2-{[2-(6-chloro-2-iodo-9H-purin-9-yl)prop-2-en-1-yl]thio}phenol (34) was obtained. Compound 34 shows activity against cancer cells. Interestingly, 34 inhibits mammosphere formation at the micromolar range,
Introduction
It is well known that cancer continues to be a major health problem in developing as well as undeveloped countries. Although major advances have been made in the chemotherapeutic management of some patients, the continued commitment to the laborious task of discovering new anticancer agents remains critically important, in the course of identifying various chemical substances which may serve as a lead for designing novel anti-tumor agents.
Breast cancer still remains as the second most common cancer worldwide. Although chemotherapy and radiotherapy can effectively reduce tumor mass and provide temporary remission, relapse occurs in many cases. This is due to an intrinsically chemotherapy-resistant subpopulation of cells with a strong ability for self-renewal, known as cancer stem cells (CSCs) (Li et al., 2008) . This subset of cells may also contribute to tumor initiation, progression and metastasis. Thus, drugs that target CSCs offer great promise for cancer treatment, particularly in combination with chemotherapy (Garcı´a-Rubin˜o et al., 2016) .
The design, synthesis and biological evaluation of a series of 2-and 6-disubstituted (RS)-9-(2,3-dihydro-1,4-benzoxathiin-3-ylmethyl)-9H-purine derivatives and the most active compounds as antiproliferative agents were 1 and 2 ( Fig. 1 ) (Dı´az-Gavila´n et al., 2008) .
We have also reported the synthesis and anti-proliferative activity against the human breast cancer cell line MCF-7 of a series of substituted (RS)-9-(2,3-dihydro-1,4-benzoxathiin-2-ylmethyl)-9H-purines 12-14. The most active compound (RS)-2,6-dichloro-9-(2,3-dihydro-1 ,4-benzoxathiin-2-ylmethyl)-9H-purine (5) shows an IC 50 = 2.75 ± 0.02 lM ( Fig. 1 ) .
The issue of chiral drug is now a major theme in the design, discovery and development of new drugs. It has been shown that for many pharmaceuticals only one enantiomer contains the desired activity, and the synthesis of such drug molecules in their optically pure form is becoming increasingly important. We have recently reported an efficient enantiospecific synthesis of the (R)-and (S)-9-(2,3-dihydro-1,4-benzoxathiin-2 and 3-ylmethyl)-9H-purines 3-5 under microwave (MW) irradiation, together with the mechanism and their corresponding anti-tumor activity against the human breast cancer cell lines MCF-7 and SKBR-3. All homochiral compounds included in this study show different apoptotic effects between both enantiomers (Garcı´a-Rubin˜o et al., 2013) .
Preparation has been developed for alkylated aminopurines with the (R)-and (S)-3,4-dihydro-2H-1,5-benzoxathiepin-3-ol moieties by the Mitsunobu reaction under microwave-assisted conditions. It reveals a complete inversion of the stereogenic center of the secondary alcohol giving an alkylated adenine linked to a homochiral sixmembered ring (Garcı´a-Rubin˜o et al., 2014) . In both publications, when (RS)-3-hydroxy-3,4-dihydro-2H-1,5-benzoxathiepin reacts with several purines under the Mitsunobu conditions, a contraction of the seven-membered ring takes place into the six-membered one. The reactions deviate from the normal behavior because the sulfur atom competes as an alternative nucleophile, through an intermediate episulfonium ion (Garcı´a-Rubin˜o et al., 2014 , 2013 .
The secondary hydroxyl group was previously transformed into the hydroxyethyleneoxy or hydroxypropyleneoxy fragments. This allowed the separation of a newly generated primary hydroxyl group of the seven-membered cycle in order to prevent the S-3 participation of neighboring group and concomitant contraction of the ring to a sixmembered cycle. With this objective, we published the synthesis and anti-tumor activity of a series of (RS)-9-[3-(3,4-dihydro-2H-1,5-benzox athiepin-3-yloxy)alkyl]-9H-purines 6-8. The most active compounds are 7 and 8 with IC 50 = 6.67 ± 0.06 lM, and 5.14 ± 0.06 lM, respectively (Fig. 1 ). Our results demonstrate that the anti-proliferative activities displayed by compounds 6-8 against the MCF-7 human breast cancer cells are due to the inhibition of protein synthesis by the eIF2a phosphorylation and inhibition of the PI3K pathway (Kimatrai et al., 2011) .
Benzoxazepins are well-known pharmacophores in medicinal chemistry showing a promising activity against various diseases such as psychosis with a central nervous system activity along with an anticancer profile against breast cancer cells (Liao et al., 1999; James et al., 1993; Mulligan et al., 2006) . One of these groups of benzoxazepins has been identified as a target for the microtubule assembly in order to induce anticancer activity (Mulligan et al., 2006) . However, amino acid-based benzoxazepins were little explored to evaluate their pharmacological activity. Syntheses of amino acid-based polycycles were reported (Mishra et al., 2007a; Panda, 2007b, 2005) . Easy availability of amino acid-based benzoxazepins promoted Samanta et al. (2010) to evaluate them for anticancer breast activity, and they designed amino acid-derived benzoxazepin derivatives with alkyl amino ethyl chains and evaluated anti-tumor activity in human breast cancer cells and a xenograft model. The most active compound was (S)-9 ( Fig. 1) (Samanta et al., 2010) .
In an attempt to further explore the biological properties of benzoxathiepins as active pharmacophores, we propose herein to prepare two different structural types: (a) a new kind of L-cysteine-based 1,5-benzoxathiepin derivatives with an amino group at position 3 of the heterocycle with an S-configuration, and (b) a purine linked to a 1,5-benzoxathiepin-derived structure.
Results and discussion

Chemistry
(3R)-Amino-3,4-dihydro-2H-1,5-benzoxathiepin [(R)-10] was diversified into two forms: (a) the incorporation of different amino acids through an amide bond, and (b) by the construction of the purine ring to give rise to a new prototype. The primary amine (R)-10 has been prepared according to a patent (Vacher et al., 2005) and its synthesis is displayed in Scheme 1. Reaction of L-cystine dimethyl ester in its form of a dihydrochloride salt [absolute configuration (R,R)] with the appropriate diazonium salt yielded the methyl (o-fluorophenyl)-Lcysteinate [absolute configuration (R)], which was reduced with lithium aluminum hydride to the corresponding (2R)-amino-3-[o-fluorophenyl)sulfanyl]propan-1-ol. This amino alcohol was finally cyclized to (R)-10. The four-step synthesis resulted in a 51% overall yield of pure (R)-10. We have prepared two derivatives of (R)-10 to confirm its structure: the acetamide (R)-11, whose structure has been corroborated by X-ray, and the p-nitrobenzenesulfonamide (R)-12 (Scheme 2).
X-ray crystallography of (R)-11
Derivative (R)-11 has been crystallized from CH 2 Cl 2 and its 3D structure has been determined using X-ray diffraction. A Fig. 1 Benzofused six-and seven-membered heterocycles with interesting anti-proliferative (1) (2) (3) (4) (5) (6) (7) (8) and anticancer [(S)-9] activities. Scheme 1 Synthesis of (R)-10 (Vacher et al., 2005) .
view of the molecule is represented in Fig. 2 . Each molecule is built up from two fused six-and seven-membered rings. The six-membered ring is planar, whereas the seven-membered ring displays a chair conformation with the puckering parameters: Q2 = 0.453(3) Å and Q3 = 0.710(3) Å , / 2 = 29.2(4)°and / 3 = 313.2(2)° (Cremer and Pople, 1975) , with a total puckering amplitude of 0.842 (2) Å (Boessenkool and Boyens, 1980) . The acetamide fragment occupies an axial position in the seven-membered ring. The absolute stereochemistry of this homochiral molecule was confirmed by a Flack parameter of À0.003(13) (Parsons et al., 2013) .
In the crystal, the acetamide moieties connect adjacent molecules by hydrogen bonding interactions generating a chain running along the a-axis (Fig. 3) . Non-classical CAH hydrogen bonds connect chains to build up the supramolecular structure.
The 1,5-benzoxathiepin scaffold linked to distinct a-amino acids
We have used several proteinogenic amino acids assorted on the basis of their structure and the general chemical characteristics of their R groups, located at position a in relation to the carboxylic acid group: acid (Glu), aliphatic (Leu), aromatic (Phe, Tyr), basic (Arg, Lys) and cyclic (Pro).
The strategy followed is shown in Scheme 3. The reaction of amine (R)-10 with different Boc-amino acids and subsequent Boc-deprotection of the corresponding derivatives is summarized in Table 1 . Amide bond formation is a fundamentally important reaction in organic synthesis, and is typically mediated by the so-called coupling reagents. Valeur and Bradley wrote a critical review on the most used coupling reagents with particular attention paid to the pros and cons of these reagents (Valeur and Bradley, 2009 ). We have used N-[3-(dimethylamino)propyl]-N 0 -ethylcarbodiimide hydrochloride (EDCÁHCl), followed by 1-hydroxybenzotriazole hydrate (HOBt) as coupling agents for amide formation.
2.1.3. Novel purine derivatives: 1. Preservation of the 3,4-dihydro-2H-1,5-benzoxathiepin scaffold and construction of the 6-chloropurine moiety linked to the seven-membered frame. 2. Ring opening when iodine is introduced at position 2 of the purine moiety At this point, we have followed a different strategy (Kimatrai et al., 2011) to preserve the seven-membered ring: We propose herein to build up the purine ring from the amino group of the 3,4-dihydro-2H-1,5-benzoxathiepin-(3R)-yl amine (R)-10. Starting from (R)-10 and according to Scheme 4, (R)-28 was obtained in a sequence of two steps: a) condensation of (R)-10 with the 5-amino-4,6-dichloropyrimidine to produce the substituted diaminopyrimidine (R)-27; and b) reaction of this product with triethyl orthoformate in an acidic medium (Scheme 4) (Dejmek et al., 2012) to produce (R)-28.
As a part of a research program on the synthesis of some biologically active heterocyclic compounds containing nitrogen, we planned to synthesize some new 6-substituted purine derivatives carrying the 9-(3,4-dihydro-2H-1,5-benzoxathiepin-(3R)-yl)-9H-purine motif, aiming at an investigation of new heterocycles with enhanced biological activity. Scheme 5 shows several substitution products of the chlorine atom, and a modification of the oxidation state of the sulfur atom of (R)-28.
We have published substitution reactions on 6-chloro-7-or 9-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)-7H-or 9H-purines (Nu´n˜ez et al., 2006) . In the present paper we find that in the amination of (R)-28 with NH 4 OH, together with ammonia, a second nucleophile arose (hydroxyl ion) and the two products (R)-29 and (R)-30 were obtained and easily purified by flash chromatography (CH 2 Cl 2 /MeOH: 9.9/0.1), eluting (R)-29 faster than (R)-30. In the case of (R)-31, the dimethylamine nucleophile results as a consequence of the decomposition of DMF under microwave irradiation, high temperature (180°C) and basic conditions in a sealed microwave vial. Finally, oxidation of the sulfur atom of (R)-28 with potassium peroxymonosulfate (OxoneÒ, Scheme 5) produces the sulfone (R)-32. We have previously used this oxidation for benzo-fused sulfurcontaining seven-membered O,N-acetals (Nu´n˜ez et al., 2007) .
In our experience, 2,6-dihalogenopurines in general show a better anti-proliferative activity than the 6-chloropurine derivatives Garcı´a-Rubin˜o et al., 2013; Kimatrai et al., 2011; Lo´pez-Cara et al., 2011; Morales et al., 2014; Morales et al., 2015) and therefore this prompted us to introduce an iodine atom at position 2 of the purine ring of (R)-28. According to the work of Taddei et al. (2004) , a regioselective 2-lithiation of 6-chloropurine derivatives is achievable at a low temperature in THF with 5 equivalents of Harpoon 0 s base (lithium 2,2,6,6-tetramethylpiperidine, LTMP). Quenching the lithiated species with 5 equivalents of tributyltin chloride affords the 2-stannylated product exclusively, and finally an iodination product under mild conditions. Scheme 3 General synthetic procedure for dipeptides made up by condensation of the L-cysteine-derived heterocyclic amine (R)-10 and Boc-protected a amino acids to give 13-19, and the corresponding deprotected derivatives 20-26. Table 1 3-(R)-Amino-3,4-dihydro-2H-1,5-benzoxathiepin has been linked to different protected a-amino acids through an amide bond to give the protected compounds 13-19, which produce 20-26, after deprotection. c N a N e -Di-Boc-l-lysine hydroxysuccinimide ester.
The opening of the seven-membered ring of the nonisolated intermediate A took place, giving rise to 33 and 34 (Scheme 6). In fact, it is well known that ethers may be cleaved by organolithium compounds and, although the rates of these reactions depend on both the structure of the organolithium compound and the ether, such cleavages may occur even at low temperatures because of the negative temperature coefficients associated with these reactions (Wakefield, 1974) .
Characterization of 33 and 34 by NMR and high resolution mass spectra (HRMS) was obtained after purification of the crude oils by flash chromatography on silica gel [(hexane/ EtOAc: 3/1) and (hexane/EtOAc: 5/1), respectively]. In both cases, 1 H NMR (in a CDCl 3 solution) showed only one purine proton (d 8.05 ppm) assignable to H-8, as a result of a 2-substitution. The 1 J, 2 J, and 3 J ( 13 C-119 Sn) couplings between the tin atom and the corresponding n-butyl aliphatic carbon atoms were observed in the 13 C NMR of 33 (see Experimental Part). As spectra of 33 and 34 are similar (and therefore with the same scaffold) and in order to justify their structures, we will develop the reasoning on the 2,6-dihalopurine derivative 34. When 1,3-benzoxathioles were heated under reflux of benzene with a lithium amide (lithium diethylamide), cleavage of a single bond (ether and thioether) or both bonds takes place (Melis et al., 1983) . However, by performing the reaction with LTMP at À78°C, we achieved the selective cleavage of the ether bond of (R)-28 to produce 33. This result may seem contradictory at first sight because the CAO bond dissociation energies are usually higher than the corresponding CAS energies (Oae and Doi, 1991) . However, one must consider that hindered lithium amides such as LTMP are useful for the selective deprotonation of functionalized molecules precisely because of the unique ability of lithium to coordinate to heteroatoms (Woltermann et al., 2004) .
We hypothesized that the first step for the cleavage of the ether/thioether bond of (R)-28 requires as the primary step coordination between lithium and the heteroatom to bring the chiral base and the substrate into close proximity, thus enforcing the removal of the proton. Such approach was previously used by Wiedemann et al. (2003) to explain the blithiation of epoxides that afford allylic alcohols, where the lithium atom of LTMP coordinates with the epoxide oxygen Scheme 5 Several substitution products of the chlorine atom, and modification of the oxidation state of the sulfur atom of (R)-28.
Scheme 4 Construction of the 6-chloropurine ring to obtain (R)-10.
to direct the abstraction of the proton by the nitrogen of the base. Coordination of the oxygen to the metal would also favor the cleavage of the C-O bond by polarizing the flanking oxygen-carbon bonds, producing a more stable leaving group (Houghton, 1979) .
Therefore, the exclusive obtainment of 34 as the reaction product would reflect the preferential coordination of the lithium of LTMP with the oxygen atom (and not the sulfur) of (R)-28, which would generate a more stable transition structure. Alternatively, the preferential abstraction of the proton by the complex when the lithium binds to the oxygen atom could also reflect a transition state structure where the proton and the nitrogen are closer to the collinearity (i.e. NAHAC optimum abstraction bond angle $180°). Wiedemann et al. (2003) also demonstrated that LTMP exists in mixtures of THF and pentane as the C 2h dimer B, whereas low concentrations of the monomer C (% 20%) appear in neat THF (Fig. 4) . Consequently, four possible transition structures (D-G, Fig. 4 ) could be formed through the coordination of lithium atoms in the aggregation/solvation states of LTMP with the oxygen or sulfur atoms of (R)-28. Based on the selective cleavage of the ether bond observed for (R)-28, one may expect that the transition structures D and F are more stable than the corresponding E and G.
Computations using density functional theory (DFT) were then employed to detail these transition states. As the computational cost for these simulations grows exponentially with the number of electrons of the system (Whitfield et al., 2013) , we used structures H to K (Fig. 5 ) as simplified models for the transition structures D to G. According to the simulations, the reaction is more likely to proceed via dimer-based than monomer-based lithiation, although nearly no difference in the enthalpy values was observed when the lithium atom of LTMP coordinated with the oxygen or the sulfur atom. However, when we look at the NAHAC bond angles, the transition structures I and K display considerable deviation from the Scheme 6 Opening of the seven-membered ring of (R)-28 when introducing iodine at position 2 of the purine ring, by using an excess of the Harpoon 0 s base and tributyltin chloride, and iodine.
optimum 180°collinear proton transfer angle (NAHAC angles = 141.08°and 124.53°, respectively) when compared to the transition structures H and J (NAHAC angles = 156.00°and 147.42°, respectively), a result that is consistent with the formation of 34.
Biological activities
MCF-7 and MDA-MB-231 human breast cancer cell lines were selected for the in vitro assays as they have proved to be excellent experimental models for the study of both tumorigenesis and metastasis as well as the efficacy of different therapies before its use in patients (Holliday and Speirs, 2011; Wilhelm et al., 2004) . Due to the similar genetic susceptibility existing among breast and ovarian cancers (Miki et al., 1994) , we decided to also test the compounds in the ovarian carcinoma SKOV-3 cell line.
Compounds evaluated for the anti-proliferative activity have been the following: (R)-29, (R)-30, (R)-31, 37, 39-45, (R)-46, (R)-47 and 56. To evaluate the anti-proliferative activity of the synthesized compounds, we consider active only those that showed an IC 50 value below or equal to 100 lM.
In the first chemical library only compound 37 showed an IC 50 = 100 lM in the three cancerous cell lines previously cited.
Compound 34 has a selective anti-proliferative effect on breast cancer cell lines
In relation to the purine-related compounds, 34 showed a selective anti-proliferative activity against breast cancer cell lines MCF-7 (IC 50 = 41.8 lM) and MDA-MB-231 (IC 50 = 20.4 lM), being inactive against SKOV-3. Interestingly, 34 did not induce significant cytotoxic effects at concentrations up to 100 lM in the non-tumor cell line of 142BR fibroblasts: 85% of the cells were viable at a concentration of 100 lM, and 91% of them at 50 lM, suggesting that the mechanism of action of the compound is selective for cancer cell lines.
Compound 34 decreases mammosphere formation in MDA-MB-231 and MCF-7 breast cancer cells
CSCs can be identified due to the ability to grow as 3D nonadherent structures when clonally seeded in serum-free media (tumor-spheres), among several characteristics (Cioce et al., 2010) . We determined the effect of 34 on MDA-MB-231 and MCF-7 breast CSCs enriched populations by growing them into low attachment plates with sphere-forming medium for 2 weeks.
As previously described (Iglesias et al., 2013) , MDA-MB-231 cells formed weak mammospheres that could be disaggregated mechanically. Nevertheless, the difference between MDA-MB-231 cells treated with vehicle or with 34 was unquestionable, as compound-treated cells were unable to grow as spheres while in DMSO-treated cultures a significant number of small-sized mammospheres were formed. In contrast to MCF-7 spherical solid masses of cells were formed upon incubation with DMSO, but this sphere formation ability was almost completely abolished by treatment with 20 lM of 34.
Importantly, the 34-induced reduction in mammosphere formation was not due to non-specific cytotoxicity. Previous experiments in monolayer cultures showed that cell viability remained as high as 60% for MDA-MB-231 cells and as 97% for MCF-7 cells in the presence of 20 lM of the compound.
Conclusions
The importance of sulfur in biological systems is known and also its increasing interest as a regulatory agent. Accordingly, the rationality that leads to the employment of sulfur-based heterocycle drugs comes to light. On the other hand, the incorporation of alpha-amino acids into heterocyclic structures is an effective strategy for generating numerous peptidomimetics and combinatorial library scaffolds. We have conducted these studies hoping to shed some light on the synthesis and reactivity of seven-membered benzo-fused diheterocycles. A diverse group of novel seven-membered heterocycles derived from naturally abundant proteinogenic amino acids have been synthesized. When (R)-28 was treated with an excess of the Harpoon's base (lithium 2,2,6,6-tetramethylpiperidine) and tributyltin/iodination, 2-{[2-(6-chloro-2-iodo-9H-purin-9-yl)prop-2-en-1-yl]thio}phenol (34) was obtained as a result of breaking the O-CH 2 bond of the sevenmembered ring. On the other hand, within the N-9 alkylated purines, 34 showed important activity against CSC. We are currently carrying out its detailed mechanistic biological studies, including the identifications of possible targets for future rational drug design.
Experimental section
General methods
Melting points were taken in open capillaries. Flash chromatography was performed on silica gel 60 with a particle size of 0.040-0.063 mm (230-400 mesh ASTM). Small scale microwave-assisted synthesis was carried out in an Initiator 13 C NMR spectrometer) at room temperature have been carried out at the University of Zaragoza. Chemical shifts (d) are quoted in parts per million (ppm) and are referenced to the residual solvent peak. Signals are designated as follows: s, singlet; bs, broad singlet, d, doublet; dd, doublet of doublets; ddd, doublet of doublet of doublets; dt, double triplet; t, triplet; m, multiplet. Highresolution Nano-Assisted Laser Desorption/Ionization (NALDI-TOF), Electrospray Ionization (ESITOF) mass spectra were carried out on a Bruker Autoflex, on a Waters LCT Premier Mass Spectrometer, and on Bruker Microtof-Q spectrometer. All the compounds gave accurate mass spectra, having the correct isotope abundance and no extraneous peaks. Small-scale microwave-assisted syntheses were carried out in a single-mode microwave instrument producing controlled irradiation at 2.450 GHz and sealed reaction vessels were used. Reaction time refers to hold time from 130°C to 160°C, not to total irradiation time. The temperature was measured with an IR sensor outside the reaction vessel. Optical rotations were measured in a cell with a 1 dm path length at the temperature indicated in each case using a JASCO P-1020 polarimeter. All evaporations were carried out in vacuum with a Bu¨chi rotary evaporator and the pressure controlled by a Vacuubrand CVCII apparatus. Anhydrous DMF was used as received.
Crystal structure determination of (R)-11
Measured crystal was prepared under inert conditions immersed in perfluoropolyether as protecting oil for manipulation. A suitable crystal was mounted on MiTeGen Micromounts, and this sample was used for data collection. Data were collected on a Bruker D8 Venture diffractometer (Cu Ka, 150 K). Data collection and processing were performed using the programs APEX3 (Bruker, 2016) and SAINT (Bruker, 2013) , and a multi-scan absorption correction was applied using SADABS (Sheldrick, 2014) . The structures were solved by direct methods (Sheldrick, 2008) , which revealed the position of all non-hydrogen atoms. These atoms were refined on F 2 by a full-matrix least-square procedure using anisotropic displacement parameters (Sheldrick, 2015) . All hydrogen atoms were located in the difference Fourier map and included as fixed contributions riding on attached atoms with isotropic thermal displacement parameters 1.2 (ACH, ACH 2 , ANAH) or 1.5 (ACH 3 ) times than those of the respective atoms. Crystallographic data of (R)-30 for structural analysis have been deposited in the Cambridge Crystallographic Data Centre, CCDC 1477918.
4.1.2. Incorporation of a-amino acids into the amino group of (R)-10 4.1.2.1. Procedure A: General procedure for amide bond formation from amine (R)-10 and Boc-Xaa-OH. To a solution of Boc-L-Xaa-OH (1.50 mmol) in CH 2 Cl 2 (30 mL), cooled to 0°C in an ice bath, was added N-[3-(dimethylamino)propyl]-N 0 -ethylcarbodiimide hydrochloride (EDCÁHCl) (316 mg, 1.65 mmol) followed by 1-hydroxybenzotriazole hydrate (HOBt) (253 mg, 1.65 mmol) and the reaction was stirred for 15 min. Then, a solution of (R)-10 (Vacher et al., 2005) (1.24 mmol) in CH 2 Cl 2 (10 mL) and N-methylmorpholine (NMM) (0.18 mL, 1.65 mmol) was added and the mixture was stirred at rt for 24 h. The reaction mixture was washed with a 5% aqueous solution of NaHCO 3 (3 Â 30 mL), followed by a 5% aqueous solution of KHSO 4 (3 Â 30 mL). The organic phase was dried (MgSO 4 ), filtered and evaporated to dryness. The crude products were purified by column chromatography to provide the corresponding compounds 13-19. 25.38, 28.71, 31.35, 32.60, 36.54, 47.98, 48.25, 51.38, 61.47, 61.74, 75.07, 75.18, 81.42, 81.60, 123.11, 124.95, 129.09, 129.38, 129.80, 133.03, 156.03, 156.42, 161.73, 161.86, 174.57, 175.03 (444 mg, 1.0 mmol) in acetone (25 mL) was added K 2 CO 3 (414 mg, 3.0 mmol) and NaI (19 mg, 0.13 mmol) followed by 2-chloroethylpiperidine chlorhydrate (276 mg, 1.5 mmol). The reaction was refluxed for 24 h. Then, the mixture was filtered and the filtrate was evaporated at reduced pressure. The crude product was purified by column chromatography (CH 2 Cl 2 / MeOH 9/1) to provide 18 as a white solid (500 mg, 0.9 mmol, 90% yield). Mp: 108-110°C. 27, 24.72, 28.30, 36.19, 37.70, 48.84, 54.63, 55.96, 57.30, 64.67, 74.28, 80.21, 114.84, 122.28, 124.05, 128.15, 128.95, 129.08, 130.42, 132.34, 155.31, 157.28, 160.78, 170.72 (19) . To a solution of Boc-L-Lys(Boc)-OSu (665 mg, 1.50 mmol) in CH 2 Cl 2 (40 mL), cooled to 0°C in an ice bath, was added a solution of (R)-10 (1.24 mmol) in CH 2 Cl 2 (10 mL). After stirring at rt for 24 h, the reaction mixture was washed with a 5% aqueous solution of NaHCO 3 (3 Â 30 mL) followed by a 5% aqueous solution of KHSO 4 (3 Â 30 mL). The organic phase was dried (MgSO 4 ), filtered and evaporated to dryness. 13 C NMR (CDCl 3 , 100 MHz): d 22. 71, 28.42, 28.56, 29.78, 32.18, 36.34, 39.98, 48.85, 54.70, 74.58, 79.22, 80.17, 122.42, 124.22, 128.35, 129.11, 132.53, 155.80, 156.27, 161.04, 171.74 07, 31.34, 36.13, 47.49, 52.25, 61.14, 74.81, 123.05, 124.96, 129.01, 129.76, 132.94, 161.63, 169.37 14, 38.81, 51.94, 55.67, 74.57, 123.01, 124.91, 128.84, 128.92, 129.71, 130.08, 130.59, 132.89, 135.66, 161.50, 169.10 , 1H) , 7.10-7.14 (m, 2H), 7.29-7.33 (m, 1H), 7.50 (dd, 1H, J = 7.6 Hz, J = 1.7 Hz).
13 C NMR (MeOH-d 4 , 100 MHz): d 21. 16, 23.11, 25.54, 36.10, 41.86, 52.12, 53.03, 74.79, 123.06, 124.95, 128.95, 129.75, 132.93, 161.61, 170.38 05 (m, 2H) , 3.02 (dd, 1H, J = 14.5 Hz, J = 5.9 Hz), 3.15 (dd, 1H, J = 14.5 Hz, J = 3.1 Hz), 3.28 (t, 2H, J = 6.8 Hz), 4.13 (dd, 1H, J = 12.8 Hz, J = 2.5 Hz), 4.19 (t, 1H, J = 6.6 Hz), 4.28 (dd, 1H, J = 12.7 Hz, J = 4.8 Hz), 4.47-4.57 (m, 1H), 7.11-7.16 (m, 2H), 7.33 (ddd, 1H, J = 8.1 Hz, J = 7.3 Hz, J = 1.7 Hz), 7.51 (dd, 1H, J = 7.7 Hz, J = 1.7 Hz).
13 C NMR (MeOH-d 4 , 100 MHz): d 25. 51, 29.84, 36.09, 41.78, 52.19, 53.97, 74.77, 123.04, 124.95, 129.00, 129.75, 132.94, 158.54, 161.55, 169.50 
To the resulting residue, a saturated solution of NaHCO 3 was added and extracted (EtOAc: 3 Â 15 mL). The combined organic extracts were dried (MgSO 4 ), filtered and evaporated to dryness. The crude compound was purified by column chromatography (CH 2 Cl 2 /MeOH: 8:2) to afford 25 as a white solid (287 mg, 0.63 mmol, 97% yield). Mp: 96-98°C. 13 C NMR (CDCl 3 , 100 MHz): d 24.14, 25.82, 36.57, 40.26, 48.47, 55.07, 56.67, 57.93, 65.85, 74.74, 114.92, 122.38, 124.14, 128.45, 128.99, 129.81, 130.42, 132.47, 157.82, 160.98, 173.95 96, 28.08, 32.18, 36.08, 40.29, 52.17, 54.12, 74.76, 123.02, 124.96, 129.03, 129.76, 132.96, 161.59, 169.66 2H) , 2.52 (t, 2H, J = 7.4 Hz), 3.00 (dd, 1H, J = 14.4 Hz, J = 6.7 Hz), 3.14 (dd, 1H, J = 14.3 Hz, J = 3.6 Hz), 4.03 (t, 1H, J = 6.4 Hz), 4. 18-4.26 (m, 2H), 4.44-4.49 (m, 1H), 6.97-7.03 (m, 2H), 7.16-7.21 (m, 1H) , 7.37 (dd, 1H, J = 7.7 Hz, J = 1.7 Hz).
13 C NMR (MeOH-d 4 , 100 MHz): d 27. 98, 30.72, 36.20, 52.03, 53.86, 74.78, 123.09, 124.96, 129.05, 129.77, 132.96, 161.71, 169.51, 176.20 82, 159.25, 131.37, 128.29, 126.98, 123.54, 121.74, 73.64, 49.79, 34.60, 22.54 C, 59.17; H, 5.87; N, 6.27. Found: C, 59.21; H, 5.99; N, 6.15 .
A solution of (R)-10 in CH 2 Cl 2 (5 mL) at rt was added to a round-bottom flask (250 mL) that contained a solution of p-nitrobenzenesulfonyl chloride (344 mg, 1.55 mmol), and 1-[3-(dimethylamino)-pro pyl]-3-ethylcarbodiimide hydrochloride (EDCl, 642 mg, 3.3 mmol) in CH 2 Cl 2 (15 mL). The resulting mixture was stirred at rt for 12 h, then cooled to 5°C, and acidified to pH 1 with addition of an aqueous HCl solution (10%), which was followed by extraction with CH 2 Cl 2 /MeOH (9:1, 3 Â 100 ml). The combined organic layers were washed with H 2 O and brine, dried (Na 2 SO 4 ), filtered and concentrated in vacuum. 2H), 2H), 7.41 (dd, J = 8.0, 1.7 Hz, 1H), 1H), 2H), 6.07 (d, J = 9.9 Hz, 1H, NH), 4.19 (ddd, J = 12.6, 3.7, 1.6 Hz, 1H), 1H), 3.76 (dd, J = 12.5, 1.9 Hz, 1H), 2.96 (dd, J = 14.4, 2.5 Hz, 1H), 2.78 (ddd, J = 14.5, 5.0, 1.6 Hz, 1H).
13 C NMR (75 MHz, CDCl 3 ): d 160. 97, 150.27, 147.43, 132.81, 129.62, 128.28, 128.00, 124.70, 122.51, 74.90, 53.28, 37.62 C, 49.17; H, 3.85; N, 7.65. Found: C, 49.32; H, 3.95; N, 
4,6-Dichloropyrimidin-5-amine (133 mg, 0.81 mmol) and Et 3 N (0.44 mL, 0.0032 mmol) were added to a solution of (R)-10 (100 mg, 0.55 mmol) in n-BuOH, and the reaction mixture was heated under reflux and stirred for 24 h under an atmosphere of dry argon. The solvent was evaporated in vacuum, and the reaction mixture was extracted (EtOAc). The organic layer was washed with H 2 O and brine, dried (Na 2 SO 4 ), filtered and concentrated in vacuum. 35, 153.60, 149.18, 143.06, 132.81, 129.38, 128.73, 124.47, 122.72, 122.54, 74.88, 50.17, 36.51 A solution of (R)-27 (654 mg, 2.05 mmol) in triethyl orthoformate (30 ml) was stirred while concentrated HCl (37%, 1.3 mL) was added in one portion; then the reaction mixture was stirred at rt for 24 h under an atmosphere of dry argon. The solvent was removed and the residue partitioned between CH 2 Cl 2 (50 mL) and H 2 O (50 mL), the phases were separated and the organic layer was washed with H 2 O and brine, dried (Na 2 SO 4 ), filtered and concentrated in vacuum. 86, 152.00, 151.58, 151.42, 145.12, 132.33, 131.41, 129.34, 126.97, 124.73, 122.41, 73.54, 55.15, 35.95 A solution of (R)-28 (100 mg, 0.3 mmol) in 1,4-dioxane (5 mL) was heated, and NH 4 OH (10 mL) was added. The reaction mixture was stirred under reflux for 6 h, then the solvent was removed in vacuum and the residue was purified by column chromatography (CH 2 Cl 2 /MeOH: 9.9/0.1) to give (R)-29 and (R)-30.
( 42, 159.21, 148.75, 145.09, 139.72, 131.96, 128.95, 126.62, 124.38, 122.24, 110.15, 73.45, 55.27, 35.88 41, 151.15, 146.77, 140.90, 132.18, 129.11, 127.05, 125.95, 124.53, 122.32, 121.97, 73.65, 54.80, 35.98 58, 154.84, 152.08, 150.07, 137.75, 131.96, 128.80, 126.94, 124.24, 122.21, 119.79, 73.66, 54.50, 38.84 36, 152.21, 151.93, 151.46, 144.69, 136.22, 134.16, 131.81, 128.44, 125.79, 123.51, 74.48, 56.27, 52.38 SCl: C, 47.94; H, 3.16; N, 15.97. Found: C, 48.01; H, 3.20; N, 15.85. 4.1.3.8. 2-({2-[6-Chloro-2-(tributylstannyl)-9H-purin-9-yl] prop-2-en-1-yl}thio)phenol (33). To a stirred solution of lithium 2,2,6,6-tetramethylpiperidine (LTMP, 2 g, 14 mmol) in dry THF (30 mL) was added (R)-28 (884 mg, 2.8 mmol) at À78°C under a positive pressure of dry argon. Following stirring at the same temperature for 10 min, Bu 3 SnCl (3.8 mL, 14 mmol) was added. After 30 min of stirring at À70°C, the reaction was quenched by adding an aqueous NH 4 Cl solution, and the mixture was partitioned between a saturated aqueous NaHCO 3 solution and EtOAc. The organic layer was purified by flash chromatography (hexane/EtOAc: 3/1) to obtain 33 (260 mg, 16%) as a yellowish syrup, 37, 150.43, 149.92, 142.89, 138.17, 136.25, 132.00, 130.90, 120.94, 116.67, 115.37, 111.35, 38.73, 29.10 OSSnCl: C, 51.38; H, 6.14; N, 9.22. Found: C, 51.23; H, 5.99; N, 9.23. 4.1.3.9 . 2-{[2-(6-Chloro-2-iodo-9H-purin-9-yl)prop-2-en-1-yl] thio}phenol (34). A solution of 33 (216 mg, 0.35 mmol) and iodine (90 mg, 0.35 mmol) in dry THF (5 ml) was stirred at rt for 24 h under a nitrogen atmosphere. The reaction mixture was diluted with a 5% aqueous Na 2 S 2 O 3 and extracted (CH 2 -Cl 2 , 3 Â 100 ml). The extract was washed with brine, dried (Na 2 SO 4 ), filtered and concentrated in vacuum. The mixture was purified by flash chromatography (hexane/EtOAc: 5/1) to give 34 (71 mg, 68%) as a yellowish solid; mp: 136-138°C; 1 H NMR (300 MHz, CDCl 3 ): d 8.05 (s, 1H, H8 0 ), 7.21-7.14 (m, 2H), 6.90 (dd, J = 8.1, 1.3 Hz, 1H), 6.74 (dt, J = 7.5, 1.3 Hz, 1H), 6.36 (s, 1H, OH), 5.30 (d, J = 1.6 Hz, 1H, H3 00 ), 5.04 (d, J = 1.9 Hz, 1H, H3 00 ), 4.14 (s, 2H, H1 00 ). 13 C NMR (75 MHz, CDCl 3 ): d 156. 95, 151.63, 150.94, 144.46, 138.00, 135.83, 132.15, 131.99, 121.03, 117.00, 116.35, 115.39, 112.95, 38.15 
Density functional theory (DFT) computations
Three-dimensional structures of the compounds were initially built using the online version of Corina (https://www.mnam.com/online_demos/corina_demo), which ascribes to 3D structures pre-defined bond lengths and angles depending on the type of bond, type of atom and hybridization state. Corina also defines the most probable torsional angles according to the nature of the structure (acyclic, small/medium rings, macro/polycyclic, etc.), being able to correctly reproduce a varied number of X-ray structures (Gasteiger et al., 1990) . Transition ground state geometries were then calculated in Spartan 14 using the DFT B3LYP functional combined with the 6-31G * basis set (Shao et al., 2006) . Although Spartan allows some calculations to be performed in THF, we performed all the simulations in vacuum because our transition state structures displayed some elements not parameterized for solvation in THF.
